Bellevue Group Portfolio holdings
Bellevue Group is a Swiss asset manager that focuses on healthcare investing, small and mid-cap companies and other growth strategies. Martin Bisang and four other founders started it in 1993, and through its subsidiary Bank am Bellevue it first became a major name in brokerage and block trading on the Swiss market. It sold that bank to Luxembourg's KBL Group in 2019, dropping its private client business and becoming a pure asset manager. In 2016 it bought the German asset manager StarCapital to build its presence in Germany, and in 2023 it launched Bellevue Obesity Solutions, a global equity fund.
Top Buys
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.12% |
| 2 | Financials | 1.6% |
| 3 | Miscellaneous | 1.28% |
Similar funds
Bellevue Group's Q1 2016 Portfolio in Review
Q1 2016 is the first quarter with a 13F filing on record for Bellevue Group, which disclosed 130 positions worth $551M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Gilead Sciences: 233,300 shares worth $21.4M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, followed by Financials and Miscellaneous.
- Bellevue Group's ten largest holdings make up 31% of its $551M portfolio in Q1 2016.
- Bellevue Group disclosed 130 positions in Q1 2016, its first 13F filing on record.
Based on Bellevue Group's 13F filing for Q1 2016, filed 16 May 2016.